Indicated for: glaucoma; ocular hypertension
Route of administration: ophthalmic
Substance: travoprost (glaucoma agent)
ATC: S01EE04 (Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues)
Travoprost is a prostaglandin F2-alpha analog used in the treatment of open-angle glaucoma and ocular hypertension. It works by increasing the outflow of aqueous humor, thereby reducing intraocular pressure and preventing optic nerve damage.
Travoprost is administered as eye drops, usually once daily in the evening. It is indicated for patients requiring effective and long-lasting intraocular pressure reduction.
Common side effects include conjunctival hyperemia, ocular irritation, changes in iris pigmentation, and eyelash growth. In rare cases, severe adverse reactions such as macular edema or allergic reactions may occur. It is important for patients to follow their doctor's instructions and avoid excessive use.
Travoprost is an effective and well-tolerated therapeutic option for managing elevated intraocular pressure, helping to prevent vision loss and maintain ocular health.